insight
✂️ 성형 🏥 중증 탈모 한방 반려 게놈 🌐 전체
← 뒤로

Androgen sensitivity gateway to COVID-19 disease severity.

✂️ 성형 🏥 중증 🦱 탈모
4/5 보강
Drug development research 📖 저널 OA 25.6% 2021: 0/5 OA 2022: 0/3 OA 2023: 0/2 OA 2024: 0/8 OA 2025: 13/28 OA 2026: 7/31 OA 2021~2026 2020 Vol.81(7) p. 771-776 피인용 10회 참고 37건 cited 167 OA RCR 5.87 Dermatological and COVID-19 studies
TL;DR The evidence presented in this communication warrants the initiation of trials using anti‐androgen agents, as the model explains why males are more likely to develop severe symptoms while children are ostensibly resistant to infection.
🔎 핵심 키워드 안드로겐성 탈모 ×2 안드로겐성 탈모 ×2 안드로겐성 탈모 ×2 감염 감염 감염 전체 NER ↓
Retraction 확인
출처
PubMed DOI PMC OpenAlex Semantic 마지막 보강 2026-05-06

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
19 patients due to severe symptoms.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Androgen sensitivity is a likely determinant of COVID-19 disease severity. We believe that the evidence presented in this communication warrants the initiation of trials using anti-androgen agents.
📑 코퍼스 인용 관계 · 인용됨 10 · 인용함 37
→ 이 논문이 인용한 논문 (4) ▾
📑 인용한 논문 (6) ▾
연도별 인용 (2020–2026) · 합계 167
OpenAlex 토픽 · Dermatological and COVID-19 studies COVID-19 Clinical Research Studies Diabetes and associated disorders

Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G

📖 무료 전문 🟢 PMC 전문 PMC7273095 🔓 OA PDF oa
PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

관련 도메인

안드로겐성 탈모 Androgenetic Alopecia 감염 Infection
📈 PRS 동향 보기 📰 Drug development research 저널 페이지 👤 Wambier CG 저자 프로필 📖 저자 OA 63.6% 🕸️ 그래프

Abstract

In this communication, we present arguments for androgen sensitivity as a likely determinant of COVID-19 disease severity. The androgen sensitivity model explains why males are more likely to develop severe symptoms while children are ostensibly resistant to infection. Further, the model explains the difference in COVID-19 mortality rates among different ethnicities. Androgen sensitivity is determined by genetic variants of the androgen receptor. The androgen receptor regulates transcription of the transmembrane protease, serine 2 (TMPRSS2), which is required for SARS-CoV-2 infectivity. TMPRSS2 primes the Spike protein of the virus, which has two consequences: diminishing viral recognition by neutralizing antibodies and activating SARS-CoV-2 for virus-cell fusion. Genetic variants that have been associated with androgenetic alopecia, prostate cancer, benign prostatic hyperplasia and polycystic ovary syndrome could be associated with host susceptibility. In addition to theoretical epidemiological and molecular mechanisms, there are reports of high rates of androgenetic alopecia of from hospitalized COVID-19 patients due to severe symptoms. Androgen sensitivity is a likely determinant of COVID-19 disease severity. We believe that the evidence presented in this communication warrants the initiation of trials using anti-androgen agents.
📝 환자 설명용 한 줄

The evidence presented in this communication warrants the initiation of trials using anti‐androgen agents, as the model explains why males are more likely to develop severe symptoms while children are

이 논문을 인용하기

↓ .bib ↓ .ris
APA 7 Wambier, C. G., Goren, A., S, V., Ramos, P. M., Ossimetha, A., Nau, G., Herrera, S., & McCoy, J. (2020). Androgen sensitivity gateway to covid-19 disease severity.. Drug development research, 81(7), 771-776. https://doi.org/10.1002/ddr.21688
Vancouver Wambier CG, Goren A, S V, Ramos PM, Ossimetha A, Nau G, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug development research. 2020;81(7):771-776. doi:10.1002/ddr.21688
AMA 11 Wambier CG, Goren A, S V, Ramos PM, Ossimetha A, Nau G, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug development research. 2020;81(7):771-776. doi:10.1002/ddr.21688
Chicago Wambier, C. G., Goren, A., S, V., Ramos, P. M., Ossimetha, A., Nau, G., Herrera, S., and McCoy, J.. 2020. "Androgen sensitivity gateway to COVID-19 disease severity." Drug development research 81 (7): 771-776. https://doi.org/10.1002/ddr.21688
MLA 9 Wambier, C. G., et al. "Androgen sensitivity gateway to COVID-19 disease severity." Drug development research, vol. 81, no. 7, 2020, pp. 771-776. doi:10.1002/ddr.21688.
PMID 32412125 ↗
DOI 10.1002/ddr.21688

추출된 의학 개체 (NER)

합병증 감염 infection 감염 infection 감염 infection
상태/진단 안드로겐성 탈모 androgenetic alopecia ×2 안드로겐성 탈모 androgenetic alopecia ×2 안드로겐성 탈모 androgenetic alopecia ×2
전체 NER 표 보기
유형영어 표현한국어 / 풀이UMLS CUI출처등장
질환 androgenetic alopecia 안드로겐성 탈모 dict 2
질환 androgenetic alopecia 안드로겐성 탈모 dict 2
질환 androgenetic alopecia 안드로겐성 탈모 dict 2
합병증 infection 감염 dict 1
합병증 infection 감염 dict 1
합병증 infection 감염 dict 1

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

인용 관계

그래프 OA 노드: 12/12 (100%) · 참조 4편 · 후속 8편

이 논문이 참조한 문헌 34

외부 PMID 30건 (DB 미수집)

이 논문을 인용한 후속 연구 10

함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

유방 (78) 피판재건술 (65) 혈종 (63) 상처열개 (46) 괴사 (45) 유방성형술 (38) 장액종 (33) 복부성형술 (22)

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능

비슷한 논문 — 같은 카테고리, 인용 많은 순

정렬
안드로겐성 탈모 · 더 보기 (2,030편) → 📖 OA만 (1,249편) 📖 한글 위키
🟢 PMC 전문 열기